582306-90-9 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-fluoro-benzamidine is utilized as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique chemical structure allows for the creation of compounds with specific biological activities, making it a valuable asset in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-4-fluoro-benzamidine serves as a crucial component in the synthesis of pesticides and other crop protection agents. Its incorporation into these products enhances their effectiveness in controlling pests and diseases, thereby supporting agricultural productivity and food security.
Used as a Reagent:
2-Chloro-4-fluoro-benzamidine also functions as a reagent in the preparation of biologically active compounds. Its ability to participate in various chemical reactions facilitates the synthesis of a broad spectrum of molecules with potential applications in research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 582306-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,2,3,0 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 582306-90:
(8*5)+(7*8)+(6*2)+(5*3)+(4*0)+(3*6)+(2*9)+(1*0)=159
159 % 10 = 9
So 582306-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClFN2.ClH/c8-6-3-4(9)1-2-5(6)7(10)11;/h1-3H,(H3,10,11);1H
582306-90-9Relevant articles and documents
INHINITORS OF GLI1 AS THERAPEUTIC AGENTS
-
Paragraph 0183, (2020/06/10)
This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to glioma- associated oncogene (Gli) expression. More particularly, this disclosure relate
Pyridine and pyrimidine derivatives
-
, (2008/06/13)
The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and X are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment